Lipoprotein-associated Phospholipase A2 (Lp-PLA2)

<strong>Lipoprotein-associated Phospholipase A2 (Lp-PLA2)</strong>_x000D_ <strong>Catalog number:</strong> B2012150_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 45 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Lp-PLA2, platelet-activating factor acetylhydrolase, PAF acetylhydrolase, PLA2G7_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: The story continues Med Res Rev. 2020 Jan;40(1):79-134._x000D_ 2: Tselepis AF, Rizzo M, Goudevenos IA. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2) Curr Pharm Des. 2011 Nov;17(33):3656-61._x000D_ 3: Vittos O, Toana B, Vittos A, Moldoveanu E. Lipoprotein-associated phospholipase_A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker Biomarkers. 2012 Jun;17(4):289-302._x000D_ 4: Ikonomidis I, Michalakeas CA, Lekakis J, Parissis J, Anastasiou-Nana M. The role of lipoprotein-associated phospholipase_A2 (Lp-PLA₂) in cardiovascular disease Rev Recent Clin Trials. 2011 May;6(2):108-13._x000D_ 5: Li J, Cao T, Wei Y, Zhang N, Zhou Z, Wang Z, Li J, Zhang Y, Wang S, Wang P, Cheng N, Ye L, Li M, Yu Y, Ding C, Tan Z, Zhan B, He Q, Bao H, Wu Y, Liu L, Li J, Xu X, Cheng X, Huang X. A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase_A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT) Dis Markers. 2021 Aug 9;2021:6258865._x000D_ 6: Tellis CC, Tselepis AD. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase_A₂ (Lp-PLA₂) bound to LDL and HDL Curr Pharm Des. 2014;20(40):6256-69._x000D_ 7: Deng M, Yin Y, Zhang Q, Zhou X, Hou G. Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis Front Immunol. 2021 May 21;12:670971._x000D_ 8: Silva IT, Mello AP, Damasceno NR. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase_A₂ (Lp-PLA₂): a review Lipids Health Dis. 2011 Sep 28;10:170._x000D_ 9: Sofogianni A, Alkagiet S, Tziomalos K. Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease Curr Pharm Des. 2018;24(3):291-296._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33187461">10: Diaconu A, Coculescu BI, Manole G, Vultur H, Coculescu EC, Stocheci CM, Tudorache IS, Dincă AL, Dincă VG. Lipoprotein-associated phospholipase A2 (Lp-PLA2) - possible diagnostic and risk biomarker in chronic ischaemic heart disease J Enzyme Inhib Med Chem. 2021 Dec;36(1):68-73. </a>_x000D_ _x000D_ <strong>Products Related to Lipoprotein-associated Phospholipase A2 (Lp-PLA2) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>